Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Strategies for larger families focus on prioritization and flexible allocations. Learn how to tailor a zero-based plan to multiple dependents.
27,842 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A viral moment about who might evangelize Elon Musk shines a light on how faith and finance intersect. This article b...
Investors often wonder if Nvidia stock should be bought before major AI events. This article breaks down historical p...
The YieldMax NVDA Option Income Strategy ETF has drawn attention for its high advertised yield, but market dynamics a...
Being first to a big-market shift can pay off, but it often costs tens of billions in dollars and investor confidence...
As oil markets swing, Noble and Transocean stand out in the offshore drilling arena. This guide breaks down which off...
When a top banker speaks, markets listen. These words from Goldman signal a continuing market flywheel that could sha...
When a payments giant tops the headline numbers, savvy investors look beyond the beat. This article breaks down why v...
Emerging renders point to a major Siri refresh: a standalone app, deeper Dynamic Island integration, and a Gemini-bas...
Best Buy surprised investors with a solid earnings beat and improving margins, sending the stock higher. This article...
Two popular aerospace ETFs pick up very different signals from the sky. This guide explains why cost, exposure, and c...